Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

SRPX2 promotes cancer cell proliferation and migration of thyroid cancer

ABSTRACT: SRPX2 promotes cancer cell proliferation and migration of thyroid cancer

PROVIDER: PRJNA975593 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24718073_1.fastq.gz	Fastqsanger.gz
	SRR24718073_2.fastq.gz	Fastqsanger.gz
	SRR24718074_1.fastq.gz	Fastqsanger.gz
	SRR24718074_2.fastq.gz	Fastqsanger.gz
	SRR24718075_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

SRPX2 promotes cancer cell proliferation and migration of thyroid cancer

Project description:We found that SRPX2 expression level was higher in thyroid tumors, and greater SRPX2 expression was closely related with a higher tumor grade and poorer clinical prognosis. SRPX2 promotes the development of papillary thyroid cancer (PTC) by promoting cell proliferation and migration

2023-12-20 | GSE233267 | GEO

lncRNA n384546 promotes thyroid papillary cancer proliferation and migration by targeting miR-145-5p to regulate AKT3

Project description:lncRNA n384546 promotes thyroid papillary cancer proliferation and migration by targeting miR-145-5p to regulate AKT3

| PRJNA513972 | ENA

HOXC10 Overexpression Promotes Cell Proliferation and Migration through Regulation of CST1 Expression in Gastric Cancer

Project description:HOXC10 Overexpression Promotes Cell Proliferation and Migration through Regulation of CST1 Expression in Gastric Cancer

| PRJNA488452 | ENA

Circular RNA YPEL2 promotes cell proliferation, migration and invasion as a biomaker in cervical cancer

Project description:Circular RNA YPEL2 promotes cell proliferation, migration and invasion as a biomaker in cervical cancer

| PRJNA723838 | ENA

lncRNA n384546 promotes thyroid papillary cancer proliferation and migration by targeting miR-145-5p to regulate AKT3

Project description:we document a novel lncRNA, n384546, which may exert its oncogenic property in PTC tumorigenesis by sponging miR-145-5p and then regulating its target AKT3.This study reveals that n384546 is an oncogenic lncRNA in human thyroid cancer.

2019-06-16 | GSE124841 | GEO

Prostaglandin F2α promotes human retinal microvascular endothelial cell proliferation and migration

Project description:Prostaglandin F2α promotes human retinal microvascular endothelial cell proliferation and migration

| PRJNA689541 | ENA

RCC2 Promotes Prostate Cancer Cell Proliferation and Migration Through Hh/GLI1 Signaling Pathway and Cancer Stem-like Cells

Project description:RCC2 Promotes Prostate Cancer Cell Proliferation and Migration Through Hh/GLI1 Signaling Pathway and Cancer Stem-like Cells

| PRJNA1032552 | ENA

GFI1 promotes gastric cancer cell HS746T proliferation

Project description:GFI1 promotes gastric cancer cell HS746T proliferation

| PRJNA475274 | ENA

NCAPG promotes the proliferation and migration of endometrial cancer via the PI3K/AKT/mTOR signaling pathway

Project description:NCAPG promotes the proliferation and migration of endometrial cancer via the PI3K/AKT/mTOR signaling pathway

| PRJNA910945 | ENA

THUMPD3 regulates alternative splicing of ECM transcripts in human lung cancer cells and promotes proliferation and migration

Project description:RNA-modifying enzymes have recently garnered considerable attention due to their relevance in cancer biology, identifying them as potential targets for novel therapeutic intervention. THUMPD3 was recently identified as an RNA methyltransferase catalysing N2-methylguanosine (m2G) within certain tRNAs. In this study, we unveil a novel role for THUMPD3 in lung cancer cells. Depletion of the enzyme from lung cancer cells significantly impairs their fitness, negatively impacting key cellular processes such as proliferation and migration. Notably, exogenous expression of THUMPD3 in normal lung fibroblasts stimulates their proliferation rate. Additionally, transcriptome-wide analyses reveal that depletion of THUMPD3 from lung cancer cells induces substantial changes in the expression of cell surface proteins, including those comprising the extracellular matrix (ECM). We further demonstrate that THUMPD3 maintains expression of an extra-domain B (EDB) containing pro-tumour isoform of Fibronectin-1 mRNA, encoding FN1, an important ECM protein. Crucially, depletion of THUMPD3 promotes an alternative splicing event that removes the EDB-encoding exon from Fibronectin-1. This is consistent with THUMPD3 depletion reducing cellular proliferation and migration. Moreover, depletion of THUMPD3 selectively and preferentially affects the alternative splicing of ECM and cell adhesion molecule encoding transcripts, as well as those encoding neurodevelopmental proteins. Overall, these findings highlight THUMPD3 as an important player in regulating cancer-relevant alternative splicing and they provide a rationale for further investigations into THUMPD3 as a candidate target in anti-cancer therapy.

2024-09-26 | GSE278089 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data